Natural Products in Chemo- or Hormone Therapy
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 4141
Special Issue Editor
Interests: cancer chemoprevention and therapy; anti-cancer phytochemicals; combination treatment; mechanistic study; biomarker/target identification
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chemo- and hormone therapy represent the two main treatments for advanced stages of most types of cancer. However, the clinical success of chemo- and hormone therapeutics is commonly limited by intrinsic or acquired drug resistance, as well as their side effects. Due to the complexity and heterogeneity in cancer genetics, it may be necessary to target multiple signaling pathways within a cancer in order to achieve durable control of the cancer. Given that chemo- and hormone therapy drugs typically have sole or few molecular targets, combinations of these drugs have been widely tested and many have shown encouraging outcomes in enhancing therapeutic effects. Nevertheless, increased toxicity associated with drug–drug combinations is a considerable challenge.
Many natural products, particularly phytochemicals, have drawn increasing interest for their potential to be non-toxic anticancer agents. Natural products are typically able to target multiple signaling molecules and cellular events, promising systemic and durable control of cancer. However, the potency of their targeting activities is usually moderate, as indicated by their relatively high-effective doses as compared to that of drugs. In addition, the bioavailability of most natural compounds is relatively low, and, as a result, their effective doses as needed in vitro can barely be achieved in vivo by oral consumption at safe dose levels.
A combination of natural compounds with chemo- and/or hormone therapy seems to be a promising strategy to overcome the disadvantages of both to achieve a synergistic effect, which indeed has been observed in many previous preclinical studies. This Special Issue aims to facilitate the advancement of this research area by broadcasting the latest findings from mechanistic studies, translational studies, and clinical trial studies. Both research and review articles will be considered.
Dr. Piwen Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural compounds
- chemotherapy
- hormone therapy
- cancer
- phytochemicals
- combination
